Summary
A correlation between specific fragile sites and cancer breakpoints has been suggested raising the question of fragile site expression as a predisposing factor in the occurrence of cancer in some persons. Before addressing the question of increased fragility among patients at high risk for cancer, we analyzed the variability of aphidicolin-induced fragile sites among nine normal persons and also among repeated samples from three of these individuals. Considerable variation in both the frequency and location of these fragile sites was observed and the data strongly suggest the significant variation of 6 of the 16 selected sites to be primarily due to sampling differences. These findings indicate that the use of fragile sites as a screening tool for patients at high risk of cancer should be carefully monitored relative to the variation inherent in both culture and individual expression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brookwell R, Daniel A, Turner G, Fishburn J (1982) The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes. Am J Med Genet 13:139–148
Daniel A (1986) Clinical implications and classification of the constitutive fragile sites. Am J Med Genet 23:419–427
Daniel A, Ekblom L, Phillips S (1984) Constitutive fragile sites 1p31, 3p14, 6q26, and 16q23 and their use as controls for false-negative results with the fragile(X). Am J Med Genet 18:483–491
De Braekeleer M, Smith B, Lin CC (1985) Fragile sites and structural rearrangements in cancer. Hum Genet 69:112–116
Glover TW, Berger C, Coyle J, Echo B (1984) DNA polymerase a-inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67:136–142
Glover TW, Coyle-Morris J, Morgan R (1986) Fragile sites: overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression. Cancer Genet Cytogenet 19:141–150
Gollin SM, Perrot LJ, Gray BA, Kletzel M (1986) Spontaneous expression of fra(11)(q23) in a patient with Ewing's sarcoma and t(11;22)(q23;q11). Cancer Genet Cytogenet 20:331–339
Hecht F, Glover TW (1984) Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. Cancer Genet Cytogenet 13:185–188
Hecht F, Hecht BK (1986) Chromosome 9 in acute lymphoblastic leukemia: breaks in band 9p21-22 and a fragile site. Cancer Genet Cytogenet 21:1–3
Jacobs PA, Glover TW, Mayer M, Fox P, Gerrard JW, Dunn HG, Herbst DS (1980) X-linked mental retardation: a study of 7 families. Am J Med Genet 7:471–489
Le Beau MM (1986) Chromosomal fragile sites and cancer-specific rearrangements. Blood 67:849–858
Le Beau MM, Rowley JD (1984) Heritable fragile sites and cancer. Nature 308:607–608
Michels VV (1985) Fragile sites on human chromosomes: description and clinical significance. Mayo Clin Proc 60:690–696
Shabtai F, Klar D, Hart J, Halbrecht I (1985) On the meaning of fragile sites in cancer risk and development. Cancer Genet Cytogenet 18:81–85
Sutherland GR (1985) Heritable fragile sites on human chromosomes. XII. Population cytogenetics. Ann Hum Genet 49:153–161
Sutherland GR, Hecht F (1985) Fragile sites on human chromosomes. Oxford University Press, New York Oxford
Sutherland GR, Parslow MI, Baker E (1985) New classes of common fragile sites induced by 5-azacytidine and bromodeoxyuridine. Hum Genet 69:233–237
Yunis JJ (1984) Recurrent chromosomal defects are found in most patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 11:125–137
Yunis JJ, Soreng AL (1984) Constitutive fragile sites and cancer. Science 226:1199–1204
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Craig-Holmes, A.P., Strong, L.C., Goodacre, A. et al. Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Hum Genet 76, 134–137 (1987). https://doi.org/10.1007/BF00284909
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00284909